iPSC-Derived Cardiomyocytes – YBLiCardio

Choose the Best Products for Your Unique Needs




iPSC-Derived Cardiomyocytes – YBLiCardio

YBLiCardio, our iPSC-derived cardiomyocytes, offer a versatile array of features suitable for a wide range of applications. These cells exhibit electrical activity and rhythmic contractions, closely mimicking the behaviour of mature cardiac cells. They display robust responses to gold-standard tool compounds, making them invaluable for acute and chronic drug testing. YBLiCardio is sensitive to cardiotoxic compounds, such as anthracyclines, TKIs, and hERG-trafficking modulators, underlining their significance in drug safety assessments. Furthermore, they maintain genomic expression patterns akin to adult human cardiac tissue. Flow cytometry analysis confirms their purity, while their viability ensures a strong starting point for experiments and research. With a good seeding efficiency during growth, YBLiCardio combines stability and reliability for long-term studies and investigations, making them a compelling choice in the field of cardiac research and drug discovery

Request Quote
YBLiCardio – Release Criteria

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote
Image caption

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C
Text link

Bold text




Download Datasheet
Download Datasheet
Refer Datasheet

Similar to 

iPSC-Derived Cardiomyocytes – YBLiCardio

No Similar Products Found